Overview

Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.

Status:
Terminated

Trial end date:
2011-10-01

Target enrollment:

Participant gender:

Summary

Lymph node biopsy followed by axillary reverse mapping may reduce the incidence and severity of arm lymphedema. This randomized phase II trial is studying how well sentinel and/or axillary lymph node biopsy with or without axillary reverse mapping works in reducing incidence and severity of lymphedema in patients with resectable stage 0-II breast cancer

Phase:

Phase 2

Details

Lead Sponsor:

University of Southern California

Collaborator:

National Cancer Institute (NCI)

Treatments:

Methylene Blue
Pharmaceutical Solutions
Technetium Tc 99m Sulfur Colloid